Syntel India Pharmaceutical Private Limited
About Syntel India Pharmaceutical Private Limited
Data last updated:
Syntel India Pharmaceutical Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2017PTC300378. Its GSTIN is 27AAZCS3024Q1ZG (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amitkumar Rajkumar Singh and Supriya Amit Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 3 Nirmal Nasari Buliding Type – D Chs Shop No.5 Khardi Gaon Diva East, Thane, Maharashtra, India – 400612.
As per the financials filed for FY 2025, the company reported a revenue of ₹78.34 Lakh, a decline of 5% compared to the previous year. For the same year it recorded a net profit of ₹35,194 (net margin 0.4%) and EBITDA of ₹35,071 (EBITDA margin 0.4%). Revenue has grown at a compounded annual rate (CAGR) of 145% over three years and 76% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Syntel India Pharmaceutical Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressD – 3 Nirmal Nasari Buliding Type – D Chs Shop No.5 Khardi Gaon Diva East, Thane, Maharashtra, India – 400612
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Syntel India Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Syntel India Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Syntel India Pharmaceutical Private Limited, buy the company report.
Financials of Syntel India Pharmaceutical Private Limited
FY 2025 filings availableSyntel India Pharmaceutical Private Limited reported revenue of ₹78.34 Lakh (down 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 5% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 76%. EBITDA fell 92% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹35,071 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹35,194 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Syntel India Pharmaceutical Private Limited, buy the company report.
Board of directors of Syntel India Pharmaceutical Private Limited
Syntel India Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amitkumar Rajkumar Singh | Director | 04 Oct 2017 | 9 Years 1 Months | Current |
| Supriya Amit Kumar Singh | Director | 30 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
Syntel India Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale and retail trade and repair of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Justgoeco Products Private Limited | ₹79.02 Lakh (FY 2025) | 66.0% | Delhi, India | |||
| Daksh Innovative Private Limited | ₹78.6 Lakh (FY 2025) | 85.0% | Bangalore, Karnataka, India | |||
| Creative Computer Systems Pvt Ltd | ₹78.5 Lakh (FY 2025) | 1.0% | New Delhi, Delhi, India | |||
| Patel Car Accessories Private Limited | ₹78.5 Lakh (FY 2025) | -54.0% | Mumbai, Maharashtra, India | |||
| Finecut Productions Private Limited | ₹78.45 Lakh (FY 2024) | -58.0% | New Delhi, Delhi, India | |||
| Syntel India Pharmaceutical Private Limitedthis company | ₹78.34 Lakh (FY 2025) | ₹35,194 | 0.4% | -5.0% | Thane, Maharashtra, India | |
| Cocktail Decor Private Limited | ₹78.29 Lakh (FY 2025) | -27.0% | Mumbai, Maharashtra, India | |||
| Highrank Properties Consultants Private Limited | ₹78.27 Lakh (FY 2024) | 98.0% | Kolkata, West Bengal, India | |||
| Prabhu Kripa Investments Private Limited | ₹78.26 Lakh (FY 2024) | 4.0% | New Delhi, Delhi, India | |||
| Future Universal Petro Solutions Private Limited | ₹78.22 Lakh (FY 2025) | Jagadhri, Haryana, India | ||||
| Vishal Fertilizer Private Limited | ₹78.18 Lakh (FY 2024) | Meerut, Uttar Pradesh, India |
To see the full peer comparison of Syntel India Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Syntel India Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Syntel India Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Syntel India Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAZCS3024Q1ZG | Maharashtra | Active | 29 Jan 2018 |
To see the full GST registrations and return filing status of Syntel India Pharmaceutical Private Limited, buy the company report.
Recent activity
Syntel India Pharmaceutical Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Manoj Patel Kumar Omkarnath ceased to be Director on 01 Nov 2021.
Frequently asked questions
Syntel India Pharmaceutical is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 October 2017 (9+ years old) and is registered under CIN U51909MH2017PTC300378.
Syntel India Pharmaceutical has 2 current directors:
- Amitkumar Rajkumar Singh - Director
- Supriya Amit Kumar Singh - Director
The latest financial statements of Syntel India Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Syntel India Pharmaceutical is 27AAZCS3024Q1ZG, registered in Maharashtra.
The CIN (Corporate Identification Number) of Syntel India Pharmaceutical is U51909MH2017PTC300378. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Syntel India Pharmaceutical was incorporated on 04 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Syntel India Pharmaceutical by revenue are Justgoeco Products Private Limited, Daksh Innovative Private Limited, Creative Computer Systems Pvt Ltd, Patel Car Accessories Private Limited, Finecut Productions Private Limited and 5 more, all in the same principal business activity (wholesale and retail trade and repair of motor vehicles and motorcycles).
Manoj Patel Kumar Omkarnath ceased to be Director on 01 Nov 2021. Vijay Tribhuvan Singh ceased to be Director on 01 Nov 2021. Supriya Amit Kumar Singh was appointed as Director on 30 Oct 2021. Syntel India Pharmaceutical has 4 board changes on record in total.
The registered office of Syntel India Pharmaceutical is at D – 3 Nirmal Nasari Buliding Type – D Chs Shop No.5 Khardi Gaon Diva East, Thane, Maharashtra, India – 400612.
Syntel India Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Syntel India Pharmaceutical is compliant as of 07 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
